PDE5A and benign prostatic hyperplasia: Among the mechanisms involved in the pathology of BPH/LUTS, the Nitric oxide (NO)/cGMP pathway has an important functional role3, and all key enzymes of this pathway, nitric oxide synthase, PKG-1 and phosphodiesterase 5 (PDE5) are expressed in the prostatic tissue.